{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:27:53Z","timestamp":1790706473498,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T00:00:00Z","timestamp":1416960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10067-014-2827-4","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T16:17:24Z","timestamp":1417537044000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis"],"prefix":"10.1007","volume":"34","author":[{"given":"Abhijeet","family":"Danve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiana","family":"Vakil-Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Dinno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,26]]},"reference":[{"key":"2827_CR1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-146-6-200703200-00005","volume":"146","author":"YPM Goekoop-Ruiterman","year":"2007","unstructured":"Goekoop-Ruiterman YPM, Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJSM, Hazes JMW et al (2007) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146:406\u2013415","journal-title":"Ann Intern Med"},{"key":"2827_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","volume":"364","author":"C Grigor","year":"2004","unstructured":"Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263\u2013269","journal-title":"Lancet"},{"key":"2827_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.20716","volume":"52","author":"K Puolakka","year":"2005","unstructured":"Puolakka K, Kautiainen H, M\u00f6tt\u00f6nen T, Hannonen P, Korpela M, Hakala M et al (2005) Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 52:36\u201341","journal-title":"Arthritis Rheum"},{"key":"2827_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.60.4.353","volume":"60","author":"A Boonen","year":"2001","unstructured":"Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden SJ (2001) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 60:353\u2013358","journal-title":"Ann Rheum Dis"},{"key":"2827_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M, Emery P, FitzGerald O, Helliwell P et al (2014) Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 73:6\u201316","journal-title":"Ann Rheum Dis"},{"key":"2827_CR6","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"issue":"Suppl 11","key":"2827_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/acr.20575","volume":"63","author":"J Zochling","year":"2011","unstructured":"Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res 63(Suppl 11):47\u201358","journal-title":"Arthritis Care Res"},{"key":"2827_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.berh.2007.02.009","volume":"21","author":"T Pincus","year":"2007","unstructured":"Pincus T, Yazici Y, Bergman M, Maclean R, Harrington T (2007) A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). Best Pract Res Clin Rheumatol 21:789\u2013804","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2827_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/kem364","volume":"47","author":"T Pincus","year":"2008","unstructured":"Pincus T, Bergman MJ, Yazici Y, Hines P, Raghupathi K, Maclean R (2008) An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 47:345\u2013349","journal-title":"Rheumatology (Oxford)"},{"key":"2827_CR10","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3899\/jrheum.080182","volume":"35","author":"T Pincus","year":"2008","unstructured":"Pincus T, Swearingen CJ, Bergman M, Yazici Y (2008) RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol 35:2136\u20132147","journal-title":"J Rheumatol"},{"key":"2827_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/RHU.0b013e3182936b98","volume":"19","author":"I Castrej\u00f3n","year":"2013","unstructured":"Castrej\u00f3n I, Bergman MJ, Pincus T (2013) MDHAQ\/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis. J Clin Rheumatol 19:169\u2013174","journal-title":"J Clin Rheumatol"},{"key":"2827_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"SM Linden van der","year":"1984","unstructured":"van der Linden SM, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"2827_CR13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25\u201331","journal-title":"Ann Rheum Dis"},{"key":"2827_CR14","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5","volume":"42","author":"T Pincus","year":"1999","unstructured":"Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42:2220\u20132230","journal-title":"Arthritis Rheum"},{"key":"2827_CR15","first-page":"1432","volume":"32","author":"T Pincus","year":"2005","unstructured":"Pincus T, Sokka T, Kautiainen H (2005) Further development of a physical function scale on a multidimensional health assessment questionnaire for standard care of patients with rheumatic diseases. J Rheumatol 32:1432\u20131439","journal-title":"J Rheumatol"},{"key":"2827_CR16","first-page":"2225","volume":"24","author":"DMFM Heijde van der","year":"1997","unstructured":"van der Heijde DMFM, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden SJEF (1997) Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol 24:2225\u20132229","journal-title":"J Rheumatol"},{"key":"2827_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landew\u00e9 R, Sieper J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18\u201324","journal-title":"Ann Rheum Dis"},{"key":"2827_CR18","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D Heijde van der","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK et al (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818","journal-title":"Ann Rheum Dis"},{"key":"2827_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/acr.20066","volume":"62","author":"T Pincus","year":"2010","unstructured":"Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell AT, Kunath AM et al (2010) RAPID3 on an MDHAQ is correlated significantly with activity levels of DAS28 and CDAI, but scored in 5 versus more than 90\u00a0seconds. Arthritis Care Res 62:181\u2013189","journal-title":"Arthritis Care Res"},{"key":"2827_CR20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/art.10824","volume":"48","author":"T Pincus","year":"2003","unstructured":"Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F et al (2003) An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20\u00a0% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 48:625\u2013630","journal-title":"Arthritis Rheum"},{"key":"2827_CR21","first-page":"2146","volume":"33","author":"T Pincus","year":"2006","unstructured":"Pincus T, Chung C, Segurado OG, Amara I, Koch GG (2006) An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol 33:2146\u20132152","journal-title":"J Rheumatol"},{"key":"2827_CR22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/acr.20481","volume":"63","author":"T Pincus","year":"2011","unstructured":"Pincus T, Furer V, Keystone E, Yazici Y, Bergman MJ, Luijtens K (2011) RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol. Arthritis Care Res 63:1142\u20131149","journal-title":"Arthritis Care Res"},{"issue":"Suppl 10","key":"2827_CR23","first-page":"48","volume":"65","author":"E Kaptanoglu","year":"2013","unstructured":"Kaptanoglu E, Sahin O, Durmaz Y, Cengiz AK, Hizmetli S (2013) Routine Assessment of Patient Index Data 3 in fibromyalgia: a rapid and reliable instrument for evaluating disease severity? Arthritis Rheum 65(Suppl 10):48","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2827-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2827-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:38Z","timestamp":1559120258000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2827-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2827"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2827-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,26]]}}}